CME Group Inc. (NASDAQ:CME) Shares Sold by Public Sector Pension Investment Board

Key Points

• The Public Sector Pension Investment Board reduced its stake in CME Group Inc. by 1.1% during the first quarter, now holding 133,976 shares valued at $35,542,000.
• Several institutions have increased their positions in CME Group, with Golden State Wealth Management LLC boosting its holdings by 612.5%, now owning 114 shares.
• CME Group announced a quarterly dividend of $1.25 per share, translating to an annualized payout of $5.00 and a yield of 1.8%.

Public Sector Pension Investment Board decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 133,976 shares of the financial services provider's stock after selling 1,551 shares during the quarter. Public Sector Pension Investment Board's holdings in CME Group were worth $35,542,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CME. AIA Group Ltd lifted its holdings in CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after purchasing an additional 2,510 shares in the last quarter. Cypress Capital Group lifted its stake in CME Group by 0.4% in the 1st quarter. Cypress Capital Group now owns 34,136 shares of the financial services provider's stock valued at $9,056,000 after buying an additional 120 shares in the last quarter. Motley Fool Asset Management LLC lifted its stake in CME Group by 2.6% in the 1st quarter. Motley Fool Asset Management LLC now owns 16,762 shares of the financial services provider's stock valued at $4,447,000 after buying an additional 425 shares in the last quarter. Independent Advisor Alliance boosted its holdings in CME Group by 10.6% in the 1st quarter. Independent Advisor Alliance now owns 9,767 shares of the financial services provider's stock worth $2,591,000 after buying an additional 940 shares during the last quarter. Finally, SouthState Corp acquired a new stake in CME Group in the 1st quarter worth about $133,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Down 3.5%

Shares of NASDAQ CME traded down $9.87 during trading on Tuesday, hitting $275.88. 2,741,043 shares of the company were exchanged, compared to its average volume of 2,052,923. The firm has a market capitalization of $99.42 billion, a PE ratio of 26.71, a P/E/G ratio of 5.07 and a beta of 0.44. CME Group Inc. has a 12-month low of $204.16 and a 12-month high of $290.79. The company has a fifty day moving average price of $275.61 and a 200-day moving average price of $266.55. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.56 EPS. As a group, equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Analyst Ratings Changes

Several research firms recently issued reports on CME. Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Citigroup lifted their price objective on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Piper Sandler lifted their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Finally, Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $261.93.

Insider Transactions at CME Group

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the sale, the director directly owned 3,668 shares in the company, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William R. Shepard purchased 256 shares of the business's stock in a transaction on Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the purchase, the director directly owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold 5,750 shares of company stock worth $1,576,294 in the last 90 days. Insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.